Low presence of CD86+ and high presence of CD206+ TAMs were clearly correlated with aggressive tumor phenotypes, such as multiple tumor number and advanced TNM stage; and were associated with a poor prognosis in survival and recurrence. The gene discussed is MRC1; the disease is neoplasm.